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Cytological aspects of pleural, peritoneal and pericardial fluids from patients with systemic 
lupus erythematosus 
Serous effusions of nine of 33 patients with systemic lupus erythematosus contained lupus 
erythematosus (LE) cells, identifiable in Papanicolaou-stained smears, wet films stained with 
toluidine blue, and cell blocks stained with haematoxylin and eosin. Specimens in which LE 
cells were found contained at least a moderate number of polymorphonuclear neutrophilic 
leucocytes. Most specimens containing LE cells also contained cells that resembled LE cells 
(tart cells), which appeared to be small macrophages that had phagocytosed a non- 
homogenized nucleus of a cell that had undergone degeneration. In 34 years of cytologic 
practice we have recognized LE cells in serous effusions only from patients who were already 
diagnosed as having systemic lupus erythematosus. 
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I N T R O D U C T I O N  
Non-organ-specific autoimmune diseases are best exemplified by systemic lupus erythema- 
tows (SLE), with its various autoimmune responses and clinical manifestations. Since the 
basic pathological changes of SLE-fibrinoid necrosis of connective tissue, vasculitis and a 
characteristic alteration of nuclear material-may take place in many different organs in any 
system of the body, its clinical manifestations are notoriously variable. Consequently, during 
the course of the disease a patient with SLE may develop inflammation of one or more serous 
membranes, resulting in pleural, peritoneal or pericardial effusion. 
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The most notable of the autoantibodies found in excess in SLE are those against nuclear 
components, resulting in the formation of immunocomplexes that are believed to cause the 
nuclei of dead or injured cells to become denatured and homogenized. Such altered nuclear 
material, first recognized in histological specimens from patients with SLE, was originally 
referred to as ‘hematoxylin-stained bodies”. Later, the term became shortened to ‘haema- 
toxylin body’, defined as a round, dense, homogeneous, cyanophilic body about the size of a 
neutrophilic leucocyte, probably consisting mainly of altered nuclear material with a small 
cytoplasmic component2. 
When a haematoxylin body becomes phagocytosed, the phagocytic cell (usually a neutro- 
philic leucocyte, occasionally an eosinophilic leucocyte or a macrophage) with its engulfed 
contents is known as an a lupus erythematosus (LE) cell. For a full account of the seren- 
dipitous discovery of the LE cell (in bone marrow) and its morphology, the interested reader 
should consult the original article by Hargraves and colleagues3 and the subsequent reviews 
by Hargraves4>’. 
Soon after its discovery in bone marrow, the LE cell was reported in peripheral blood6, and 
it has subsequently been found in pleural, peritoneal and pericardial fluids. Most of the well- 
documented and illustrated examples of LE cells in serous fluids from patients with SLE were 
derived from pleural with the next most frequently publised source being pericardial 
and the least common being peritoneal fluid”. Some of these publications also 
mentioned the other types of cells that were present in the effusions: various mixtures of 
leucocytes (of all types) and mesothelial cells. It is obvious that these other cells did not make 
any contribution to the diagnosis of SLE. 
In all of the publications referred to above, the techniques used to prepare the specimens 
were those customarily used for routine cytological examination. None described incubating 
a specimen at 37T ,  which used to be part of the standard procedure for detecting LE cells in 
peripheral blood. Some of the illustrated LE cells were found in smears or wet films of the cell 
sediment obtained by centrifugation, whereas others were found in cell block preparations. 
Furthermore, the stains used were either the Papanicolaou stain, toluidine blue, a 
Romanowsky stain, or haematoxylin and eosin. 
Since it is possible to find LE cells in pleural, peritoneal or pericardial fluids, it is appro- 
priate to enquire as to the frequency with which patients with SLE develop such effusions. 
This information has been supplied by Dubois & Wallace24 in a comprehensive cumulative 
review of the prevalence of clinical, biochemical, haematological and immunological mani- 
festations of SLE in 1420 patients with the disease. At some stage of the disease, pleural 
effusion developed in 1640% of patients and peritoneal effusion in 9-1 1 O h ;  pericarditis, with 
or without effusion, developed in 6 4 5 % .  A cumulative review by the same authors showed 
that up to 3% of patients with SLE developed either pleural effusion or pericarditis as an 
initial manifestation of the disease24. Ascites as the presenting feature of SLE is less common, 
although a few cases have been reported28. Over the last 34 years we have examined 36 serous 
fluids from 33 patients known to have SLE. In every case the effusion was attributable to 
SLE or to one of its complications. We reviewed the cytological findings in these fluids to find 
out the prevalence of LE cells in the specimens, to observe the morphological features of LE 
cells, and to note any other cytological findings that might signify a patient had SLE. 
Undoubtedly, over the 34 years of our laboratory’s existence we received serous fluids from 
other patients with SLE but were not made aware that these patients had the disease. 
Consequently, the fluids from these patients did not come under review; to detect these 
additional cases would have required us to review about 10 000 medical records. 
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Table 1. Serous fluids containing lupus 
erythematosus cells: cytological findings 
No. of specimens (9 patients) 9 
Hacmatoxylin bodies 6 
Necrotic cells 4 
Neutrophils: 
Moderate to abundant 9 
Absent to few 0 
Tart cells 5 
MATERIALS A N D  METHODS 
We re-examined the cytological preparations of 36 specimens of fluid from the 33 patients 
with serous effusions attributed to SLE. To verify the diagnosis of SLE, the medical records 
of all 33 patients were reviewed. These patients were identified either from our routine 
records, where a report had mentioned that LE cells were or were not seen, or from follow-up 
studies which revealed that certain serous effusions had been caused by SLE. In the former 
group we were aware that the patients had SLE when we first examined the fluids, whereas in 
the latter group we were not. 
The serous fluids were sent to the cytopathology laboratory in a fresh, non-anticoagulated 
state. Any coagulum was removed, compressed to reduce its volume, fixed in formalin and 
processed as a piece of tissue to become part of a haematoxylin and eosin-stained cell block. 
The sediment obtained by centrifugation of the fluids was smeared, fixed while wet and 
stained by the Papanicolaou technique. We also prepared a toluidine blue-stained wet film of 
the sediment, a routine procedure in our laboratory. Any remaining sediment was solidified 
by a plasma-thrombin clot technique for preparing cell blocks, then sectioned and stained 
with haematoxylin and eosin. 
In re-examining the cytological specimens, particular attention was paid to the degree of 
cellularity and the presence of the following: LE cells, cells that simulated LE cells (tart 
cells), naked background particles of homogenized nuclear material (haematoxylin bodies), 
necrotic cells and leucocytes. Differential cell counts were not performed on any of the 
specimens since it is not the custom of our laboratory to do this. We noted, however, the 
approximate proportions of the different types of leucocytes in each specimen. 
R E S U L T S  
A total of 36 specimens of serous fluid (29 pleural, five peritoneal, two pericardial), were 
examined from 33 patients (27 female, six male) who had been diagnosed on clinical and 
immunological grounds as having SLE. Their ages ranged from 5 to 62 years, with a mean of 
33 years (female, 32; male, 38) and a median of 33 years (female, 32; male, 40). 
In nine of the 33 patients, one or more specimens of serous fluid contained LE cells. Eight 
of the nine patients had pleural effusion and one had pericardial effusion. All of the patients 
with LE cells in their fluids were female. The presence of LE cells, haematoxylin bodies, 
necrotic cells, tart cells and neutrophil leucocytes in the specimens is summarized in Table 1. 
LE cells and haematoxylin bodies were found not only in routinely prepared Papanicolaou 
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Figure 1. Smear of pericardial 
fluid. This illustrates a typical 
lupus erythematosus cell, 
consisting of a homogeneous 
nuclear mass in the cytoplasm 
of a neutrophilic leucocyte. 
Papanicolaou. x 1320. 
Figure 2. Stained wet film of 
pleural fluid. This illustrates a 
well-formed lupus 
erythematosus (LE) cell 
(centre). The background 
contains an incompletely 
developed LE cell (left of 
centre) and two haematoxylin 
bodies (above centre). Other 
cells are showing karyorrhexis. 
Toluidine blue. x 1320. 
stained smears (Figure 1) but also in toluidine blue-stained wet films (Figure 2) and cell block 
preparations. 
Generally LE cells contained only a single cytoplasmic inclusion; occasionally two or three 
were present. Haematoxylin bodies were usually solitary, but occasionally were found in 
small clusters (Figure 3). In Papanicolaou-stained smears, the phagocytosed haematoxylin 
bodies of LE cells as well as non-phagocytosed haematoxylin bodies showed a variety of 
staining reactions: shades of grey, green, purple and blue. In toluidine blue-stained wet films 
the staining reaction of the phagocytosed and non-phagocytosed haematoxylin bodies was 
deep blue, and in cell blocks purple-pink to deep blue. In addition to LE cells and haema- 
toxylin bodies, smears of four of the 36 specimens contained a background heavy in nuclear 
fragments and necrotic particles. 
All serous fluids containing LE cells also contained readily found, though not necessarily 
predominating, neutrophilic leucocytes (Table 1). The background cytological picture 
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Figure 3. Cell block of 
pericardial fluid. A cluster of 
haematoxylin bodies in a 
background of fibrin. H&E. 
x 1320. 
associated with LE cells was quite variable with respect to the number of lymphocytes, 
plasma cells, macrophages, neutrophilic leucocytes and mesothelial cells, confirming a 
similar observation made by Spriggs & Boddington2’,22. 
DISCUSSION 
In our review of 36 serous effusions from 33 patients with SLE, we found LE cells in smears, 
cell blocks and stained wet films of nine patients, all women. In five of the nine cases, 
howcvcr, LE cells were not observed until we carried out a retrospective review of the 
specimens, which illustrates how easily they can be overlooked. LE cells may be quite readily 
found in a serous fluid (especially if they are being deliberately searched for) or they may be so 
few that several minutes of careful searching are required to find any. Having become more 
aware of the possibility of finding (or overlooking) LE cells in serous fluids, we expect the 
proportion of undetected examples to diminish. 
A history of a patient having SLE may well facilitate the finding of LE cells. It is important, 
however, to be aware that a serous effusion may be the first clinical manifestation of SLE and 
that such a fluid may contain LE cells. Since SLE is found predominantly in women (only six 
of our 33 patients with SLE were male), and since many of the patients are young, with 11 of 
our 33 patients being below the age of 20 years, it is important to bear in mind that an 
unexplained serous effusion in a young person, especially a female, may be caused by SLE, 
and a deliberate search for LE cells in the fluid should be carried out. 
During a search for LE cells one may also come across examples of cells referred to as ‘tart 
cells’. In announcing their discovery of the LE cell, Hargraves and colleagues3 also described 
a cell in bone marrow aspirates morphologically similar to an LE cell; such cells may also be 
seen in serous fluids. They appear to be small macrophages that have phagocytosed a non- 
homogeneous nucleus of another cell (Figure 4), presumably a cell that died and underwent 
cytolysis, thereby releasing a bare nucleus. Hargraves and colleagues3 named these cells ‘tart 
cells’, not because they were likened to a form of pastry but because the last name of the 
patient in whose bone marrow they were first found in tremendous numbers was Tart. They 
have also been referred to as ‘pseudo-LE cells’22. 
If they are looked for, tart cells can be found in most serous effusions, no matter wha-t 
caused the effusion. The morphological difference between the inclusions in tart cells and 
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Figure 4. Cell block of pleural 
fluid. Tart cell. This patient had 
systemic lupus erythematosus, 
but lupus erythematosus cells 
were not found in the fluid. 
H&E x 1320. (Reproduced 
with permission from Naylor 
B. Pleural, peritoneal and 
pericardial fluids. In: Bibbo M, 
ed, Comprehensive 
Cytopathology. Philadelphia: 
W B  Saunders, 1991; 571.) 
those in LE cells have been described in detail by Hargraves4, and may be summarized by 
stating that in the former the phagocytosed nuclear material is not homogenous whereas in 
the latter the inclusions possess a smooth homogeneity or near homogeneity. 
The formation of LE cells is generally regarded as an in vitro phenomenon, especially since 
serous fluids allowed to stand at  room temperature may contain far more LE cells than the 
same fluid examined shortly after it was aspirated”’*’. However, several authors2’$*’ found 
LE cells in pleural fluids very shortly after the fluids had been aspirated, which supports the 
idea that LE cells can develop in vivo. LE cells have been found in smears of blister and 
in direct smears of blood obtained from constricted cyanotic fingers from patients with 
SLE3’; in each of these situations the smears were made within seconds of the specimens being 
collected, which strongly suggests that LE cells can form in vivo. 
Apart from the reported examples of LE cells in serous fluids of patients with SLE, there 
are reports of LE cells in pleural and peritoneal fluids from patients who developed an SLE- 
like syndrome secondary to the taking of certain d r ~ g s ~ ’ - ~ ’ .  In these drug-induced examples 
of the LE phenomenon, the LE cells were morphologically indistinguishable from those 
found in patients with non-drug-induced SLE and, as in some cases of SLE, they were 
sometimes found in the serous fluid before they were found in peripheral blood. Therefore, 
when LE cells are found in a serous fluid their presence should be reported, but unless a drug 
induced reaction can be ruled out one should not conclude that the patient has SLE. In 34 
years of cytological practice, however, we have not come across an example of drug-induced 
LE cells in a serous effusion. 
The cytological literature describes two examples of ‘atypical’ cells in pleural fluids from 
patients with SLE. The earlier of these reports36 depicted cells that were mistaken for neo- 
plastic cells. It is obvious from the illustrations that the ‘atypical’ cells were hypertrophic 
mesothelial cells, a non-specific finding. Equally nonspecific were the ‘atypical’ cell; depicted 
in a later publication3’, which reported such cells in pleural fluids from 10 patients with SLE 
as being ‘characteristic of systemic lupus erythematosus’. Again, the cells illustrated in the 
pleural fluids had the morphologic features of hypertrophic mesothelial cells. The authors 
also illustrated ‘atypical’ cells in a histologic section of inflamed pleura from one of the 
patients. The illustration depicted hypertrophic mesothelial cells accompanied by lymphoid 
and plasmacytoid cells in the pleural connective tissue. 
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It would be most imprudent to allow the presence of hypertrophic mesothelial cells or 
plasmacytoid cells in serous fluids to point to or even suggest a diagnosis of SLE. Entirely 
non-specific and non-characteristic of SLE, they are commonly seen in serous fluids from 
patients with a wide variety of diseases. The only cell that has any diagnostic significance in 
SLE is the LE cell, with or without accompanying haematoxylin bodies. 
The labour intensive LE test on peripheral blood is now obsolete, having been supplanted 
by a variety of other immunological tests of equal or superior reliability. Because of this, 
cytological examination of routinely processed serous fluids now offers the best opportunity 
for observing the cytological curiosity that is the LE cell. 
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